Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.36B |
| 2 |
Tesla
TSLA
|
+$984M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$662M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$575M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$574M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.05B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$505M |
| 3 |
Amazon
AMZN
|
+$473M |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$439M |
| 5 |
iShares Core MSCI Europe ETF
IEUR
|
+$346M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.23% |
| 2 | Consumer Discretionary | 2.03% |
| 3 | Financials | 1.67% |
| 4 | Communication Services | 1.15% |
| 5 | Healthcare | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
CALL
Teradata
TDC
$2.57B
| $1.57M | ﹤0.01% |
50,500
-56,000
| -53% | -$1.96M |
|
4577
CALL
Agios Pharmaceuticals
AGIO
$2B
| $1.57M | ﹤0.01% |
55,400
-13,700
| -20% | -$367K |
|
4578
Evolent Health
EVH
$527M
| $1.57M | ﹤0.01% |
43,610
-4,964
| -10% | -$175K |
|
4579
Health Catalyst
HCAT
$132M
| $1.57M | ﹤0.01% |
161,526
+108,125
| +202% | +$1.43M |
|
4580
PUT
Scotiabank
BNS
$111B
| $1.56M | ﹤0.01% |
32,900
+10,900
| +50% | +$623K |
|
|
BINI
4581
CALL
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
4582
Brookfield Renewable
BEPC
$6.66B
| $1.56M | ﹤0.01% |
47,816
+41,166
| +619% | +$1.58M |
|
4583
PUT
State Street
STT
$52.2B
| $1.56M | ﹤0.01% |
25,700
-78,200
| -75% | -$5.35M |
|
4584
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.2B
| $1.56M | ﹤0.01% |
+46,014
| New | +$1.48M |
|
|
MACAU
4585
DELISTED
Moringa Acquisition Corp Units
MACAU
| $1.56M | ﹤0.01% |
157,099
+6,916
| +5% | +$68.4K |
|
4586
CALL
Globus Medical
GMED
$11.5B
| $1.56M | ﹤0.01% |
26,200
-30,700
| -54% | -$1.85M |
|
|
VRN
4587
DELISTED
Veren
VRN
| $1.56M | ﹤0.01% |
253,302
-245,920
| -49% | -$1.76M |
|
4588
Teucrium Soybean Fund
SOYB
$60.5M
| $1.56M | ﹤0.01% |
59,655
-46,924
| -44% | -$1.24M |
|
4589
Adient
ADNT
$1.54B
| $1.56M | ﹤0.01% |
56,099
+10,129
| +22% | +$329K |
|
4590
JPMorgan US Value Factor ETF
JVAL
$876M
| $1.56M | ﹤0.01% |
52,267
-66,571
| -56% | -$2.22M |
|
4591
TaskUs
TASK
$667M
| $1.56M | ﹤0.01% |
96,683
+75,770
| +362% | +$1.34M |
|
4592
PUT
System1
SST
$17.8M
| $1.56M | ﹤0.01% |
24,730
+1,270
| +5% | +$111K |
|
4593
CALL
ArcelorMittal
MT
$55.2B
| $1.55M | ﹤0.01% |
78,100
+54,700
| +234% | +$1.25M |
|
|
QVMT
4594
Invesco S&P 500 Concentrated QVM ETF
QVMT
$138M
| $1.55M | ﹤0.01% |
42,967
+25,854
| +151% | +$1.05M |
|
4595
Signet Jewelers
SIG
$3.6B
| $1.55M | ﹤0.01% |
27,132
-83,867
| -76% | -$5.05M |
|
4596
PUT
Clearfield
CLFD
$390M
| $1.55M | ﹤0.01% |
+14,800
| New | +$1.44M |
|
4597
JPMorgan Municipal ETF
JMUB
$8.52B
| $1.55M | ﹤0.01% |
31,997
-70,935
| -69% | -$3.56M |
|
4598
PTC Therapeutics
PTCT
$6.01B
| $1.55M | ﹤0.01% |
30,820
-12,091
| -28% | -$592K |
|
4599
PUT
Duolingo
DUOL
$6.74B
| $1.54M | ﹤0.01% |
16,200
-19,200
| -54% | -$1.87M |
|
|
FOLD
4600
CALL
DELISTED
Amicus Therapeutics
FOLD
| $1.54M | ﹤0.01% |
147,800
+6,300
| +4% | +$70.2K |
|
Similar funds
Jane Street's Q3 2022 Portfolio in Review
As of Q3 2022, Jane Street held 11,057 positions worth $229B, down 3.1% from $236B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Jane Street's Q3 2022 filing shows 1,520 new, 3,775 increased, 4,205 reduced and 1,444 closed positions. Its largest new stake was iShares Gold Trust: 8,373,079 shares worth $264M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.05B.
By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jane Street's largest Q3 2022 buy was iShares Gold Trust: 8,373,079 shares worth $264M.
- Jane Street added most to Invesco QQQ Trust in Q3 2022, an estimated $1.36B increase.
- Jane Street's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.05B.
- Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2022, selling an estimated $187M.
- Jane Street's ten largest holdings make up 35% of its $229B portfolio in Q3 2022.
- Jane Street opened 1,520 new positions and closed 1,444 in Q3 2022.
- Jane Street's portfolio value fell 3.1% quarter-over-quarter to $229B.
Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.